ACCP Critical Care PRN,
ATHOS pilot study in distributive shock found angiotensin II reduced norepinephrine requirements #critPRN https://bit.ly/2HsLRX3
ATHOS pilot study in distributive shock found angiotensin II reduced norepinephrine requirements #critPRN https://bit.ly/2HsLRX3
Josh Farkas at PulmCrit just released an excellent post detailing his concerns about angiotensin II. There are questions…
The FDA just approved angiotensin II (Giapreza) for use as a vasopressor in septic or other distributive shock. It has shown…